J&J | GJELD




Debt Endring Dato
AbbVie USD 67.14B 3.94B 2024-12
Abbott USD 14.98B 225M 2024-09
Amgen USD 60.1B 299M 2024-12
AstraZeneca USD 30.3B 1.27B 2024-12
Baxter International USD 13.13B 191M 2024-12
Bayer EUR 40.7B 465M 2024-12
Becton, Dickinson and Co. USD 18.76B 1.35B 2024-12
Biogen USD 6.3B 1.9M 2024-12
Boston Scientific USD 10.75B 139M 2024-12
Bristol-Myers Squibb USD 49.65B 103M 2024-12
CONMED USD 905.78M 35.03M 2024-12
Cooper Companies USD 2.54B 43.8M 2025-01
Dexcom USD 2.5B 2.1M 2024-12
Edwards Lifesciences USD 597.7M 200K 2024-12
Eli Lilly USD 33.64B 2.52B 2024-12
Gilead Sciences USD 26.71B 3.46B 2024-12
GlaxoSmithKline GBP 16.99B 927M 2024-12
Globus Medical USD 443.88M 5M 2024-12
Hologic USD 2.54B 9.7M 2024-12
Indivior 284M 3M 2024-09
Insulet USD 1.39B 6.2M 2024-12
Integra LifeSciences USD 1.8B 3.5M 2024-12
Intuitive Surgical USD 0 0 2024-09
J&J USD 36.63B 883M 2024-12
Medtronic USD 26.61B 1.72B 2025-01
Merck USD 37.11B 1.02B 2024-12
Merit Medical Systems USD 729.55M 20.95M 2024-12
Novartis USD 31.26B 828M 2024-12
Pfizer USD 64.35B 3.35B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2024-12
Roche Holding CHF 34.44B 5.23B 2024-06
Sanofi 23.75B 5.33B 2024-06
Stryker USD 13.6B 1.89B 2024-12
Tandem Diabetes Care USD 348.94M 502K 2024-12
Teva Pharmaceutical Industries USD 18.08B 901M 2024-12
Vertex Pharmaceuticals USD 112.8M 1.2M 2024-12
Zimmer Biomet Holdings USD 6.2B 246.1M 2024-12
Zoetis USD 6.57B 4M 2024-12



J&J GJELD - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.